Cross-border access to clinical trials: participation of pediatric patients and language inclusion

The SJD Barcelona Children's Hospital Clinical Trials Unit operates under a one-stop-shop model, managing clinical studies with a special focus on rare diseases, centralizing all the needs of international patients (translations, accommodation, visas, etc.). The inclusion of international patients in pediatric clinical studies is feasible. Pediatric rare diseases require a small sample of patients, highly specialized sites, and flexibility to accommodate the necessary translations for patients. The final decision regarding the inclusion of international patients lies with the sponsor. Flexibility in including international patients directly impacts the study plan and execution, preventing time deviations.

Authors

Institutions

Publication Details

Journal
Pediatric Research
Published
2026-02-17
DOI
https://doi.org/10.1038/s41390-026-04820-z
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cross-border access to clinical trials: participation of pediatric patients and language inclusion

Laura Solé, Marta Morales, Andrés Libreros Morales, Cristina Llanos et al.
Pediatric Research
Ethics in Clinical Research
article

Cross-border access to clinical trials: participation of pediatric patients and language inclusion

Laura Solé, Marta Morales, Andrés Libreros Morales, Cristina Llanos, Merçè Pineda, Bob Phillips, Susana Rives, Jaume Català-Mora, Claudia Fortuny, Begonya Nafria, Àngels García Cazorla, David Roe, Andrés Nascimento, Marta Cubells, Sandra López, Elisenda Sans
article en

Abstract

The SJD Barcelona Children's Hospital Clinical Trials Unit operates under a one-stop-shop model, managing clinical studies with a special focus on rare diseases, centralizing all the needs of international patients (translations, accommodation, visas, etc.). The inclusion of international patients in pediatric clinical studies is feasible. Pediatric rare diseases require a small sample of patients, highly specialized sites, and flexibility to accommodate the necessary translations for patients. The final decision regarding the inclusion of international patients lies with the sponsor. Flexibility in including international patients directly impacts the study plan and execution, preventing time deviations.

Pediatric Research
Hospital Sant Joan de Déu Barcelona (ES), Leeds Teaching Hospitals NHS Trust (GB), Universitat Internacional de Catalunya (ES), Sant Joan de Déu Research Foundation (ES), University of York (GB)
Reduced inequalities
Openalex Percentile: Top 56%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cross-border access to clinical trials: participation of pediatric patients and language inclusion — Laura Solé, Marta Morales, et al. · Pediatric Research (2026) | TGRS Research Map | TGRS